改善院外心脏骤停后适当的神经功能预后评估:阶梯楔形整群随机对照试验
该阶梯楔形整群随机对照试验纳入18家安大略省医院ICU的905例院外心脏骤停患者,评估多层面质量干预(教育、路径、本地骨干、审计反馈)对神经功能预后评估适当性的影响。干预后适当神经功能预后评估率从68%升至74%(OR 1.79,95%CI 1.01-3.19,P=0.05)。但出院生存率(46% vs 50%,OR 1.71,95%CI 0.97-3.01,P=0.06)和良好神经功能结局生存率(38% vs 43%,OR 1.43,95%CI 0.84-2.86,P=0.19)无显著差异。
要点
- 干预后适当神经功能预后评估率从68%升至74%(OR 1.79,95%CI 1.01-3.19,P=0.05)。
- 出院生存率干预前后分别为50%和46%(OR 1.71,95%CI 0.97-3.01,P=0.06),无显著差异。
- 良好神经功能结局生存率干预前后分别为43%和38%(OR 1.43,95%CI 0.84-2.86,P=0.19),无显著差异。
- 适当神经功能预后评估定义包括:72小时内不基于不良预后估计早期撤除生命支持治疗,或72小时至7天无不良预后临床预测因素时不撤除,或存活超过7天。
适用人群与场景
- 18家安大略省医院ICU收治的院外心脏骤停患者,2011年6月1日至2014年6月30日期间共纳入905例。
诊断标准与关键阈值
- 适当神经功能预后评估定义:(1a)72小时内不基于不良神经预后估计撤除生命支持治疗(WLST),且(1b)72小时至7天无不良神经预后临床预测因素时不撤除WLST,或(2)存活超过7天。
处置流程与药物剂量
- 多层面质量干预包括教育、路径、本地骨干和审计反馈。
研究设计与关键结果
- 研究类型:阶梯楔形整群随机对照试验,纳入18家医院ICU的905例院外心脏骤停患者。
- 主要终点:适当神经功能预后评估率干预后74% vs 干预前68%(OR 1.79,95%CI 1.01-3.19,P=0.05)。
- 次要终点:出院生存率干预后50% vs 干预前46%(OR 1.71,95%CI 0.97-3.01,P=0.06),无显著差异。
- 次要终点:良好神经功能结局生存率干预后43% vs 干预前38%(OR 1.43,95%CI 0.84-2.86,P=0.19),无显著差异。
证据类型、等级与局限
- 证据类型:多中心阶梯楔形整群随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该质量干预可提高院外心脏骤停后适当神经功能预后评估率,但未显著提高出院生存率或良好神经功能结局生存率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Predictions about neurologic prognosis that are based on early clinical findings after out-of-hospital cardiac arrest (OHCA) are often inaccurate and may lead to premature decisions to withdraw life-sustaining treatments (LST) in patients who might otherwise survive with good neurologic outcomes.
OBJECTIVES: To improve adherence to recommendations for appropriate neurologic prognostication after OHCA and reduce deaths from premature decisions to withdraw LST.
METHODS: This was a pragmatic stepped wedge cluster randomized controlled trial evaluating a multifaceted quality intervention (education, pathways, local champions, audit-feedback). The primary outcome was appropriate neurologic prognostication, defined as (1a) no early withdrawal of LST (WLST) (within 72 h) based on estimates of poor neurologic prognosis and (1b) no WLST between 72 hours and 7 days in absence of clinical predictors of poor neurologic prognosis or (2) surviving beyond 7 days. Secondary outcomes were deaths from early WLST and survival with good neurologic outcome.
MEASUREMENTS AND MAIN RESULTS: Between June 1, 2011, and June 30, 2014, a total of 905 patients with OHCA were enrolled from ICUs of 18 Ontario hospitals. Rates of appropriate neurologic prognostication increased after the intervention (68% vs. 74% patients; odds ratio [OR], 1.79; 95% confidence interval [CI], 1.01-3.19; P = 0.05). However, rates of survival to hospital discharge (46% vs. 50%; OR, 1.71; 95% CI, 0.97-3.01; P = 0.06) and survival with good neurologic outcome remained similar (38% vs. 43%; OR, 1.43; 95% CI, 0.84-2.86; P = 0.19).
CONCLUSIONS: A multicenter quality intervention improved rates of appropriate neurologic prognostication after OHCA but did not increase survival with good neurologic outcome. Clinical trial registered with www.clinicaltrials.gov (NCT 01472458).
参考来源
- Scales DC, Golan E, Pinto R, et al. Improving Appropriate Neurologic Prognostication after Cardiac Arrest. A Stepped Wedge Cluster Randomized Controlled Trial. Am J Respir Crit Care Med. 2016. PMID: 27115286
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。